Artificial Intelligence

Philips Expands & Integrates Echo AI Platform

Philips’ ultrasound AI strategy took another big step this week, with the launch of its next-generation echo AI platform, which will come integrated with the company’s cardiovascular ultrasound systems and bring a range of new echo-automating capabilities. 

Philips’ new AI-enabled cardiovascular ultrasound platform includes a combination of established and first-to-market AI applications that come fully integrated with its EPIQ CVx and Affiniti CVx echo scanners, with a focus on speeding up echo teams’ cardiac ultrasound analysis.

The announcement specifically highlighted Philips’ first-of-their-kind…

  • Segmented Wall Motion app – an automated tool for segmental wall motion scoring and identifying disorders such as coronary artery disease and cardio-oncology issues.
  • 3D Mitral Regurgitation Volume Quantification app a tool for the automated analysis of MR flow dynamics, supporting valve treatment decision-making (not yet FDA cleared).

The platform also includes solutions for automated LVEF measurements, LV strain analysis, and the automated selection of the most appropriate LV images.

Philips has been developing echo AI solutions for some time through its ultrasound and Tomtec teams, and boosted its echo AI portfolio and development capabilities through its acquisition of DIA Image Analysis almost exactly one year ago.

However, this launch is perhaps most notable for bringing the “deep” integration of AI tools into Philips’ cardiovascular ultrasound systems, making AI a core part of its scanners’ feature set and value proposition, rather than an add-on.

  • That integration could be particularly notable from a usability perspective, and could also help drive AI adoption given the continued barriers experienced when selling / buying AI as standalone solutions. 
  • It might also be a sign of an echo AI integration trend, noting that GE HealthCare has been steadily expanding its Caption AI echo guidance solution to more of its echo scanners since acquiring Caption Health last year.

The Takeaway

With all the imaging AI acquisitions that have taken place over the last few years, Philips’ echo AI integration is a reminder why the only acquisitions made by the big OEMs targeted cardiovascular ultrasound AI solutions (no other indications or modalities). 

AI tools like these make cardiovascular ultrasound systems faster and easier to use, and scanner integrations like these might have a multiplying effect on echo AI’s adoption and overall impact.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Electrophysiology August 21, 2025

Conduction-System Pacing Succeeds at Treating AV Block August 21, 2025

Conduction-system pacing could be poised to reshape standard care for atrioventricular (AV) block patients after the randomized CSPACE trial demonstrated its significant benefits over traditional right ventricular septal pacing. Taking a closer look at CSP’s potential, the CSPACE trial enrolled 202 patients with AV block at two Australian hospitals, randomizing them to conduction-system pacing or […]

Cardiology Pharmaceuticals August 18, 2025

Rivaroxaban Monotherapy Could Be Better for CAD + AFib August 18, 2025

New analysis from the AFIRE trial suggests rivaroxaban monotherapy might be emerging as a preferred antithrombotic strategy for patients with AFib and stable coronary artery disease, especially in older age groups. The Post Hoc AFIRE Analysis examined 2,215 Japanese patients with AFib and stable CAD, stratifying them into four age groups (<70, 70-74, 75-79, and […]

Surgeries & Interventions August 14, 2025

TEER Could Save Lives in AFMR Patients August 14, 2025

Shedding light on a new treatment for an understudied condition, data published in EHJ suggests that transcatheter edge-to-edge repair (TEER) delivers significant survival advantages in patients with atrial functional mitral regurgitation (FMR). The new OCEAN-Mitral/REVEAL-AFMR Analysis compared 441 TEER-treated patients against 640 medically managed controls with moderate or severe atrial FMR, stating a solid case […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!